Found: 134
Select item for more details and to access through your institution.
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning.
- Published in:
- Nature Reviews Immunology, 2013, v. 13, n. 9, p. 693, doi. 10.1038/nri3516
- By:
- Publication type:
- Article
HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo Activation.
- Published in:
- Scientific Reports, 2016, p. 20987, doi. 10.1038/srep20987
- By:
- Publication type:
- Article
Activation and lysis of human CD4 cells latently infected with HIV-1.
- Published in:
- Scientific Reports, 2015, p. 8447, doi. 10.1038/ncomms9447
- By:
- Publication type:
- Article
Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation.
- Published in:
- Scientific Reports, 2015, p. 8925, doi. 10.1038/srep08925
- By:
- Publication type:
- Article
Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193773
- By:
- Publication type:
- Article
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 3, p. 1, doi. 10.1371/journal.ppat.1006860
- By:
- Publication type:
- Article
Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 1, p. 1, doi. 10.1371/journal.ppat.1006074
- By:
- Publication type:
- Article
Vaccines: Engineering immune evasion.
- Published in:
- Nature, 2006, v. 441, n. 7090, p. 161, doi. 10.1038/441161a
- By:
- Publication type:
- Article
The gene product Murr1 restricts HIV-1 replication in resting CD4<sup>+</sup> lymphocytes.
- Published in:
- Nature, 2003, v. 426, n. 6968, p. 853, doi. 10.1038/nature02171
- By:
- Publication type:
- Article
Protection of calves by a prefusion-stabilized bovine RSV F vaccine.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0005-9
- By:
- Publication type:
- Article
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0016-6
- By:
- Publication type:
- Article
Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 765, doi. 10.3390/vaccines8040765
- By:
- Publication type:
- Article
Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03335-4
- By:
- Publication type:
- Article
Activation and lysis of human CD4 cells latently infected with HIV-1.
- Published in:
- Nature Communications, 2015, v. 6, n. 10, p. 8447, doi. 10.1038/ncomms9447
- By:
- Publication type:
- Article
Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 583, p. 1, doi. 10.1126/scitranslmed.abe5449
- By:
- Publication type:
- Article
Multiple roles for HIV broadly neutralizing antibodies.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 516, p. 1, doi. 10.1126/scitranslmed.aaz2686
- By:
- Publication type:
- Article
A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 492, p. N.PAG, doi. 10.1126/scitranslmed.aav3113
- By:
- Publication type:
- Article
Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 408, p. 1, doi. 10.1126/scitranslmed.aao4235
- By:
- Publication type:
- Article
Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron.
- Published in:
- PLoS ONE, 2022, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0268767
- By:
- Publication type:
- Article
Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 4, p. 1, doi. 10.1371/journal.ppat.1005537
- By:
- Publication type:
- Article
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 3, p. 1, doi. 10.1371/journal.ppat.1005520
- By:
- Publication type:
- Article
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody.
- Published in:
- Nature, 2012, v. 491, n. 7424, p. 406, doi. 10.1038/nature11544
- By:
- Publication type:
- Article
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.
- Published in:
- 2009
- By:
- Publication type:
- Letter
HIV/AIDS: Allied responses.
- Published in:
- Nature, 2007, v. 449, n. 7158, p. 29, doi. 10.1038/449029a
- By:
- Publication type:
- Article
SARS-CoV-2 Viral Variants-Tackling a Moving Target.
- Published in:
- 2021
- By:
- Publication type:
- editorial
Monoclonal Antibodies for Prevention and Treatment of COVID-19.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Eliminating antibody polyreactivity through addition of N-linked glycosylation.
- Published in:
- Protein Science: A Publication of the Protein Society, 2015, v. 24, n. 6, p. 1019, doi. 10.1002/pro.2682
- By:
- Publication type:
- Article
Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection.
- Published in:
- PLoS Computational Biology, 2016, v. 12, n. 5, p. 1, doi. 10.1371/journal.pcbi.1004940
- By:
- Publication type:
- Article
Improvement of antibody functionality by structure-guided paratope engraftment.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08658-4
- By:
- Publication type:
- Article
Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-07851-1
- By:
- Publication type:
- Article
Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-06424-6
- By:
- Publication type:
- Article
AIDS vaccines.
- Published in:
- 1994
- By:
- Publication type:
- Editorial
In vitro reconstitution of B cell receptor-antigen interactions to evaluate potential vaccine candidates.
- Published in:
- Nature Protocols, 2016, v. 11, n. 2, p. 193, doi. 10.1038/nprot.2016.009
- By:
- Publication type:
- Article
TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 2, p. 1, doi. 10.1371/journal.ppat.1009339
- By:
- Publication type:
- Article
Accurate Prediction for Antibody Resistance of Clinical HIV-1 Isolates.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-50635-w
- By:
- Publication type:
- Article
SONAR: A High-Throughput Pipeline for Inferring Antibody Ontogenies from Longitudinal sequencing of B Cell Transcripts.
- Published in:
- Frontiers in Immunology, 2016, p. 1, doi. 10.3389/fimmu.2016.00372
- By:
- Publication type:
- Article
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21954-2
- By:
- Publication type:
- Article
Immunologic Strategies for Herpes Vaccination.
- Published in:
- JAMA: Journal of the American Medical Association, 2000, v. 283, n. 6, p. 746, doi. 10.1001/jama.283.6.746
- By:
- Publication type:
- Article
Herpes simplex virus vaccines--why don't antibodies protect?
- Published in:
- 1999
- By:
- Publication type:
- commentary
Homologous Boosting with Adenoviral Serotype 5 HIV Vaccine (rAd5) Vector Can Boost Antibody Responses despite Preexisting Vector-Specific Immunity in a Randomized Phase I Clinical Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0106240
- By:
- Publication type:
- Article
Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (IM), Subcutaneous (SC) and Intradermal (ID) Administration (VRC 011).
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091366
- By:
- Publication type:
- Article
DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0059340
- By:
- Publication type:
- Article
N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055701
- By:
- Publication type:
- Article
Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses.
- Published in:
- PLoS ONE, 2010, v. 5, n. 2, p. 1, doi. 10.1371/journal.pone.0009015
- By:
- Publication type:
- Article